| PMCF Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops" (NCT05824000) | C.O.C. Farmaceutici S.r.l. | 2022-06-07 |
| The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis (NCT05234554) | Aldeyra Therapeutics, Inc. | 2022-01-21 |
| A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis (NCT05314621) | Andover Research Eye Institute | 2021-12-31 |
| A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis (NCT05265910) | Andover Research Eye Institute | 2021-12-14 |
| Airway Immune Response to Allergens (Use Lay Language Here) (NCT04619017) | JOSALYN CHO | 2021-10-28 |
| Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children (NCT04810390) | Faes Farma, S.A. | 2021-03-26 |
| Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment (NCT04776096) | Laboratorios Poen | 2021-03-10 |
| Sea Water in Allergic Conjunctivitis (NCT04695795) | University of Valencia | 2021-02-01 |
| Tyrosine Allergoid Paediatric and Adult Study (NCT05186025) | Allergy Therapeutics | 2020-11-06 |
| Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis (NCT04532710) | Marinomed Biotech AG | 2020-08-04 |
| Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels (NCT04389034) | Allergy Therapeutics | 2020-04-22 |
| Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface (NCT04198740) | Centre hospitalier de l'Université de Montréal (CHUM) | 2020-02-01 |
| Manuka Eye Droops for Treatment of Allergy (NCT03862053) | Toyos Clinic | 2020-01-01 |
| A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis (NCT04050865) | Ocular Therapeutix, Inc. | 2019-08-05 |
| Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest (NCT03820154) | Prof. Dr. Claus Bachert BVBA | 2019-03-01 |
| Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray (NCT03755557) | Marinomed Biotech AG | 2018-11-19 |
| Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study (NCT03682965) | Christopher Thompson, MD | 2018-09-28 |
| A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis (NCT03660878) | Aldeyra Therapeutics, Inc. | 2018-09-08 |
| China Red Eye Study on Allergic Conjunctivitis (NCT03812952) | Sun Yat-sen University | 2018-08-01 |
| Molekule for Allergic Rhinitis/Asthma (NCT03627689) | Molekule | 2018-07-13 |
| A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle (NCT03489941) | Bausch & Lomb Incorporated | 2018-04-07 |
| A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. (NCT03479307) | Faes Farma, S.A. | 2018-04-07 |
| ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis (NCT03494504) | Aldeyra Therapeutics, Inc. | 2018-03-30 |
| Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis (NCT03368339) | Realm Therapeutics, Inc. | 2017-12-10 |
| Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis (NCT03320434) | ORA, Inc. | 2017-10-13 |
| A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model (NCT03231969) | Faes Farma, S.A. | 2017-07-20 |
| Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC (NCT04641130) | Alyatec | 2017-07-13 |
| Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections (NCT03038971) | Woodmont Pharmaceuticals, Inc. | 2017-03-30 |
| Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis (NCT02978183) | Noveome Biotherapeutics, formerly Stemnion | 2016-12-01 |
| A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts (NCT01012752) | Roxall Medizin | 2016-10-01 |
| Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers (NCT03101618) | Gachon University Gil Medical Center | 2016-08-24 |
| A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis (NCT02578914) | Aldeyra Therapeutics, Inc. | 2015-08-01 |
| The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel (NCT01686048) | Meir Medical Center | 2015-04-01 |
| A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy (NCT02308501) | ORA, Inc. | 2014-12-01 |
| Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations (NCT03861910) | Federico II University | 2014-12-01 |
| Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis (NCT01657240) | Laboratorios Sophia S.A de C.V. | 2014-11-01 |
| Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis (NCT02079649) | Alcon Research | 2014-04-01 |
| A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) (NCT02082899) | Eleven Biotherapeutics | 2014-02-01 |
| Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan (NCT02251613) | Alcon Research | 2013-12-01 |
| A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle (NCT01881113) | Aciex Therapeutics, Inc. | 2013-06-01 |
| Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis (NCT01860664) | Koffler Vision Group | 2013-05-01 |
| The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions (NCT01878929) | University Hospitals Cleveland Medical Center | 2013-04-01 |
| Ocular Allergy Treatment Practical Impact Trial (NCT01808768) | Starx Research Center, LLC | 2013-04-01 |
| AGN-229666 for the Treatment of Allergic Conjunctivitis (NCT01754766) | Allergan | 2012-10-01 |
| A Six-Week Safety Study of an Investigational Ophthalmic Solution (NCT01698814) | Alcon Research | 2012-10-01 |
| A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle (NCT01685242) | Aciex Therapeutics, Inc. | 2012-09-01 |
| Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients (NCT01697969) | Alcon Research | 2012-09-01 |
| Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes (NCT01679015) | Schwartz Laser Eye Center | 2012-08-01 |
| Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis (NCT01639846) | C.T. Development America, Inc. | 2012-07-01 |
| A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) (NCT01551056) | Aciex Therapeutics, Inc. | 2012-03-01 |
| An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis (NCT01561521) | Akorn, Inc. | 2012-03-01 |
| Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model (NCT01479374) | Alcon Research | 2012-01-01 |
| Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model (NCT01534195) | ORA, Inc. | 2012-01-01 |
| An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo (NCT01439815) | ORA, Inc. | 2011-09-01 |
| Comparison of Tolerability Between Two Allergy Drops (NCT01390961) | Hom, Milton M., OD, FAAO | 2011-08-01 |
| Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis (NCT01320553) | Sun Pharma Advanced Research Company Limited | 2011-06-01 |
| Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses (NCT01337557) | Hom, Milton M., OD, FAAO | 2011-05-01 |
| The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer (NCT01346371) | Minnesota Eye Consultants, P.A. | 2011-05-01 |
| A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis (NCT01272089) | Alcon Research | 2011-05-01 |
| Safety and Comfort of AL-4943A Ophthalmic Solution (NCT01326858) | Alcon Research | 2011-04-01 |
| A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft (NCT01339507) | Cunningham, Derek N., O.D., P.A. | 2011-04-01 |
| Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model (NCT01332188) | Aciex Therapeutics, Inc. | 2011-04-01 |
| Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis (NCT01731249) | Stallergenes Greer | 2010-11-01 |
| Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients (NCT01203540) | Laboratoires Thea | 2010-10-01 |
| Patient Perception Study for AL-4943A (NCT01294969) | Alcon Research | 2010-09-01 |
| Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers (NCT01159015) | Bausch & Lomb Incorporated | 2010-07-01 |
| Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis (NCT01159769) | Alcon Research | 2010-06-01 |
| Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients (NCT01174823) | Bausch & Lomb Incorporated | 2010-06-01 |
| Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model (NCT01134328) | Aciex Therapeutics, Inc. | 2010-05-01 |
| Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis (NCT01120132) | Fovea Pharmaceuticals SA | 2010-05-01 |
| Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge (NCT01107405) | Bausch & Lomb Incorporated | 2010-04-01 |
| Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients (NCT01109485) | Alcon Research | 2010-03-01 |
| Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis (NCT01119287) | Alcon Research | 2010-03-01 |
| An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis (NCT01037179) | Alcon Research | 2010-02-01 |
| AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation (NCT01001091) | Alcon Research | 2009-12-01 |
| Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects (NCT00987272) | Alcon Research | 2009-10-01 |
| The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo (NCT01471184) | Bitop AG | 2009-09-01 |
| To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge (NCT00881673) | Alcon Research | 2009-05-01 |
| Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis (NCT00882687) | Shire | 2009-04-24 |
| Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers (NCT00889252) | Vistakon Pharmaceuticals | 2009-04-01 |
| Safety and Efficacy Study of a Eye Drop for Eye Allergy (NCT00889330) | Vistakon Pharmaceuticals | 2009-04-01 |
| Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis (NCT00836485) | Senju USA, Inc. | 2009-02-01 |
| Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation (NCT00833495) | Fovea Pharmaceuticals SA | 2009-01-01 |
| Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. (NCT00769886) | Bausch & Lomb Incorporated | 2008-10-01 |
| A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season (NCT00982163) | ORA, Inc. | 2008-08-01 |
| Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) (NCT00818805) | Alcon Research | 2008-07-01 |
| Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model (NCT00689078) | ORA, Inc. | 2008-05-01 |
| Olopatadine Eye Drops and Allergy Skin Testing (NCT00775658) | Vanderbilt University Medical Center | 2008-01-01 |
| Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR (NCT00574379) | Faes Farma, S.A. | 2007-12-01 |
| Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers (NCT00569777) | Vistakon Pharmaceuticals | 2007-10-01 |
| Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis (NCT00586664) | Bausch & Lomb Incorporated | 2007-10-01 |
| Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis (NCT00534794) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers (NCT00586625) | Bausch & Lomb Incorporated | 2007-10-01 |
| Comparison of CL Wear Between Two Allergy Drops (NCT00489398) | Hom, Milton M., OD, FAAO | 2007-07-01 |
| Montelukast as a Controller of Atopic Syndrome (NCT00559546) | University of Helsinki | 2007-03-01 |
| Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis (NCT00445874) | Vistakon Pharmaceuticals | 2007-02-01 |
| Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis (NCT00432757) | Vistakon Pharmaceuticals | 2007-01-01 |
| Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis (NCT00423007) | Bausch & Lomb Incorporated | 2006-11-01 |
| Mast-Cell Stabilizing Effects of Olopatadine (NCT00389025) | Alcon Research | 2006-10-01 |
| Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis (NCT00364091) | Vistakon Pharmaceuticals | 2006-08-01 |